glp 1 serena williams Inside Williams' partnership with Ro for GLP-1s Serena Williams and the coming
Description
That background matters when youre trusting someone with your metabolic health
Jardiance is superior
To date, the SURPASS program includes nine ongoing randomized controlled trials in patients with type2 diabetes: SURPASS 1 in monotherapy, SURPASS 2 versus semaglutide, SURPASS 3 versus degludec, SURPASS 4 versus glargine and established CV disease, SURPSS 5 basal insulin add-on, SURPASS AP- Combo versus glargine, and SURPASS-CVOT
Therapy in GLP-1 receptor agonist overdose is mainly supportive
But Lilly is hitting a bigger market
